 Solution

Quarantine restricts contacts of exposed people whose infection status is uncertain and monitors them for illness, reducing opportunities for transmission before infection is recognized. Recognized cases are managed by isolation rather than treated as merely uncertain exposures. Duration must be measured from the last possible infection-producing exposure, or otherwise account for uncertainty in exposure time. The mathematical calculations below concern the incubation period among infected people who develop symptoms, not a complete infectiousness model.

With a credible hard endpoint $M$, the truncated distribution hasA duration $q\ge M$ then covers all symptom-onset times under that model, provided the exposure time is correctly specified. If a nonzero late-onset probability $\epsilon$ is accepted, solveThe calculation is appropriate when external biological evidence genuinely supports a hard maximum, or when a deliberately bounded model is justified for the population being considered. Truncation caused by a study's ascertainment window instead requires an observation correction: it does not prove that the disease has a hard biological endpoint. Nor does $\hat{M}=t_{(n)}$ guarantee that future cases will develop symptoms by the current sample maximum. Endpoint and nuisance-parameter uncertainty need to enter a conservative duration calculation.

For an untruncated gamma distribution, lognormal distribution or other model with an unbounded upper tail, no finite duration eliminates the modeled late-onset probability. Choose a tail tolerance and solveThis is appropriate when a hard endpoint is unsupported and rare long incubation times remain possible. One can estimate a high quantile, assess its uncertainty and balance the modeled residual probability against the costs of longer restrictions. Different tail families can give very different high quantiles even when they fit the central observations similarly, which makes the model dependence seen in part b operationally relevant.

If an individual has already remained symptom-free for $a$ time units after a known exposure, a conditional additional duration $b$ instead uses $S(a+b)/S(a)\le \epsilon$, where $S$ is the relevant survivor function and $S(a)>0$. This conditions on being an infected eventual symptomatic case. Incubation data alone do not describe asymptomatic infection, the timing of infectiousness or compliance with restrictions; symptom surveillance, testing where informative and a transmission model may therefore be needed to translate late onset into an actual release-risk calculation. Use a hard bound only when it is supported; otherwise quantify and allow for the upper-tail uncertainty.